Global Patient Recruitment Services and Patient Retention Services Markets 2022-2035: Increasing Availability of Providers Offering One-Stop-Solutions as Clinical Trials Continually Increase Globally – ResearchAndMarkets.com

Global Patient Recruitment Services and Patient Retention Services Markets 2022-2035: Increasing Availability of Providers Offering One-Stop-Solutions as Clinical Trials Continually Increase Globally – ResearchAndMarkets.com




Global Patient Recruitment Services and Patient Retention Services Markets 2022-2035: Increasing Availability of Providers Offering One-Stop-Solutions as Clinical Trials Continually Increase Globally – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Patient Recruitment Services and Patient Retention Services Market by Patient Recruitment Step, Trial Phase Therapeutic Area and Key Geographies, Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering.

The report features an extensive study of the current market landscape and future potential of the patient recruitment and patient retention services market, over the next decade.

Retaining patients is a major concern in pharmaceutical research and development; 15% to 40% of the enrolled patients drop out before the studies are completed, significantly impacting product approvals / launch timelines.

The conduct of such trials are often fraught with challenges, including scientific and operational complexity, concerns associated with recruitment and retention of suitable patients, issues related to data handling and increasingly stringent regulatory guidelines.

Patient outreach, patient recruitment and patient retention strategies have evolved significantly, especially with the availability of a variety of digital data generation, management and marketing solutions. In fact, a number of modern technology-enabled offerings are now available to support various aspects of clinical research and patient recruitment.

Key Questions Answered:

What is the current market landscape of the patient recruitment and patient retention services market?

Amongst several known challenges, patient recruitment is considered to be one of the rate limiting steps when it comes to getting drugs to the market. Presently, more than 155 companies have the required capabilities to offer patient recruitment services and patient retention services across different geographical locations.

How has outsourcing evolved in the patient recruitment and patient retention domain?

Several small and mid-sized players do not have dedicated patient enrolment teams and lack the necessary capabilities / expertise to successfully recruit desired number of patients in clinical trials. In some cases, the clinical studies are too large or geographically broad to be managed by internal staff.

What are the recent developments and expected trends in the patient recruitment and patient retention domain?

Over the past decade, the patient recruitment and patient retention industry has witnessed tremendous increase in the use of social media platforms, including Facebook, Instagram, Pinterest, LinkedIn and Twitter, and mobile applications for engaging and recruiting patients in clinical studies; these approaches are cost-effective and can be used to connect with diverse and hard-to-reach patient populations.

What are the key challenges faced by patient recruitment and patient retention service providers?

The primary challenge faced by patient recruitment and patient retention service providers is the lack of awareness amongst individuals regarding the clinical studies and the benefits offered to study participants.

What are the key value drivers in the patient recruitment and patient retention service market?

Owing to rise in the number of clinical trials that seek to enroll millions of patients, and complexities associated with patient accrual, drug developers are likely to outsource the patient recruitment and patient retention process to service providers.

What is the current market scenario and likely growth associated with patient recruitment services domain?

The patient recruitment services market is anticipated to grow at a steady pace in the coming years. Owing to the need for large and diverse patient populations, phase III trials are anticipated to be responsible for the maximum share of revenues within this domain.

Scope of the Report

  • A general overview of the clinical trials, featuring information on the different phases of clinical trials and their importance. The chapter also lays emphasis on patient recruitment process, its associated challenges and the different strategies used to enhance patient enrollment in clinical research studies.
  • A brief information on the various types of patient outreach methods used by contract service providers in this domain
  • A detailed assessment of the overall landscape of companies offering patient recruitment and patient retention services
  • A detailed competitiveness analysis of patient recruitment and patient retention service providers
  • Elaborate profiles of prominent players
  • An insightful analysis of the recent collaborations within the patient recruitment and patient retention industry
  • A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence
  • A detailed discussion on the key growth opportunities such as rise in the number of clinical trials, development of personalized medicines / orphan drugs, growing opportunities in emerging markets, increasing preference for one-stop solutions, stringent regulations related to patient enrollment and technological advancements in clinical trial conduct
  • A case study on regulatory landscape of patient recruitment, highlighting the regulatory process involved in patient enrollment, along with the information on regulatory guidelines, regulatory framework for patient recruitment, ethics committees in different countries and documents reviewed by the ethics committees.
  • A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases
  • A detailed analysis of the annual demand for study participants
  • A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and patient retention services market

The report features detailed transcripts of interviews held with the following individuals:

  • Susan Fitzpatrick-Napier (Founder and Director, TrialWire)
  • Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials)
  • Simon Klaasen (Co-founder and Managing Director, Link2Trials)
  • Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness)
  • Ken Shore (Chief Commercial Officer, Continuum Clinical)
  • Hagit Nof (Chief Operation Officer and Business Development Officer, nRollmed)
  • Paul Ivsin (Ex-Managing Director, Seeker Health)
  • Kasturi Lakhe (Inside Sales Specialist, EVERSANA)

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview

3.2. Overview of Clinical Trials

3.3. Patient Recruitment in Clinical Trials

3.4. Outsourcing Patient Recruitment

3.5. Patient Retention

3.6. Concluding Remarks

4. PATIENT OUTREACH METHODS

4.1. Chapter Overview

4.2. Patient Outreach Methods

5. MARKET LANDSCAPE

5.1. Chapter Overview

5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape

6. COMPANY COMPETITIVENESS ANALYSIS

6.1. Chapter Overview

6.2. Assumptions and Key Parameters

6.3. Methodology

6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis

7. COMPANY PROFILES: PATIENT RECRUITMENT AND RETENTION SERVICES PROVIDERS IN NORTH AMERICA

7.1. Chapter Overview

7.2. BBK Worldwide (A Publicis Health Company)

7.3. Continuum Clinical

7.4. IQVIA

7.5. United BioSource (UBC)

7.6. WCG ThreeWire

8. COMPANY PROFILES: PATIENT RECRUITMENT AND RETENTION SERVICES PROVIDERS IN EUROPE

8.1. Chapter Overview

8.2. Clariness

8.3. Ignite Data

8.4. Innovative Trials

8.5. One Research

8.6. Orphan Reach

9. COMPANY PROFILES: PATIENT RECRUITMENT AND RETENTION SERVICES PROVIDERS IN ASIA-PACIFIC AND REST OF THE WORLD

9.1. Chapter Overview

9.2. 3H Medi Solution

9.3. Buzzreach

9.4. Current Medical Information Center (CMIC)

9.5. nRollmed

9.6. Trialfacts

10. PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview

10.2. Partnership Models

10.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations

11. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION

11.1. Campaigning on Social Media to Accelerate Patient Recruitment in Clinical Trials

11.2. Adoption of Mobile Technologies for Patient Recruitment and Retention

11.3. Use of EHR Data to Improve Patient Recruitment Rates

11.4. Use of Other Real-World Data Sources to Overcome Patient Enrollment-related Challenges

11.5. Use of Artificial Intelligence to Improve Patient Selection

11.6. Increase in Adoption of the Virtual Trial Model During the COVID-19 Pandemic

11.7. Growing Focus on Conducting Clinical Research in Emerging Markets

12. FUTURE GROWTH OPPORTUNITIES IN PATIENT RECRUITMENT

12.1. Chapter Overview

12.2. Continuous Rise in the Number of Global Clinical Trials

12.3. Rise in Demand for Orphan Drugs and Personalized Medicine

12.4. Increase in Offshoring Clinical Development Activity to Emerging Regions

12.5. Availability of Service Providers Offering One-Stop-Solutions

12.6. Stringent Regulations and Complex Study Protocols Prompting More Outsourcing

12.7. Impact of the COVID-19 Pandemic on Clinical Research Activity

12.8. Technological Advances in Clinical Trial Conduct

13. CASE STUDY: REGULATORY LANDSCAPE OF PATIENT RECRUITMENT

13.1. Chapter Overview

13.2. Regulatory Framework of Patient Recruitment

13.3. Regulations Involved in Patient Recruitment

13.3.1. ICH-GCP Guidelines

13.3.2. Declaration of Helsinki

13.3.3. General Data Privacy Regulation (GDPR)

13.3.4. Health Insurance Portability and Accountability Act (HIPAA)

14. PATIENT RECRUITMENT IN TRIALS FOCUSED ON PERSONALIZED MEDICINES AND RARE DISEASES

14.1. Chapter Overview

14.2. Clinical Trials Focused on Personalized Medicines and Rare Diseases

14.2.1. Key Challenges

14.2.2. Specialized Patient Outreach Methods

14.2.3. Key Players

15. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS

15.1. Chapter Overview

15.2. Scope and Methodology

15.3. Clinical Trial Analysis

15.4. Global Demand for Clinical Trial Participants

16. MARKET SIZING AND OPPORTUNITY ANALYSIS

16.1. Chapter Overview

16.2. Forecast Methodology and Key Assumptions

16.3. Global Patient Recruitment Services Market, 2022-2035

16.4. Patient Recruitment Services Market: Analysis by Patient Recruitment Steps, 2022-2035

16.5. Patient Recruitment Services Market: Analysis by Trial Phase, 2022-2035

16.6. Patient Recruitment Services Market: Analysis by Therapeutic Area, 2022-2035

17. IMPACT OF THE COVID-19 PANDEMIC ON PATIENT RECRUITMENT SERVICES MARKET

17.1. Chapter Overview

17.2. Impact of COVID-19 Pandemic on Clinical Trials

17.2.1. Impact on Opportunity Related to Patient Recruitment Services

17.2.2. Initiatives Undertaken by Key Patient Recruitment and Retention Service Providers

17.2.2.1. Trialspark

17.2.2.2. BBK Worldwide

17.2.2.3. Clariness

17.2.2.4. Clinical Site Services (CSSi)

17.2.2.5. IQVIA

17.3. Key Strategies Adopted to Mitigate the Challenges Associated with Patient Recruitment and Retention

18. CONCLUDING REMARKS

19. EXECUTIVE INSIGHTS

For more information about this report visit https://www.researchandmarkets.com/r/4mkq8e

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900